85 related articles for article (PubMed ID: 21280316)
21. [Analysis of the result of 409 cases with liver cirrhosis and severe hepatitis by using the model for end-stage liver disease].
Song CH; Chen LM; Zhang LX
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):168-70. PubMed ID: 17653326
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of the level of hepatitis delta virus RNA in serum, by real-time polymerase chain reaction--and its possible correlation with the clinical stage of liver disease.
Yamashiro T; Nagayama K; Enomoto N; Watanabe H; Miyagi T; Nakasone H; Sakugawa H; Watanabe M
J Infect Dis; 2004 Apr; 189(7):1151-7. PubMed ID: 15031781
[TBL] [Abstract][Full Text] [Related]
23. Serum CA 125 levels in patients with chronic lymphocytic leukemia.
Bairey O; Shaklai M
Clin Lab Haematol; 2005 Feb; 27(1):57-60. PubMed ID: 15686509
[TBL] [Abstract][Full Text] [Related]
24. Improvement of clinical staging in cervical cancer with serum squamous cell carcinoma antigen and CA 125 determinations.
Massuger LF; Koper NP; Thomas CM; Dom KE; Schijf CP
Gynecol Oncol; 1997 Mar; 64(3):473-6. PubMed ID: 9062153
[TBL] [Abstract][Full Text] [Related]
25. The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI.
Kim HS; Kim JW; Cho JY; Chung HH; Park NH; Song YS; Kim SH; Kang SB
Eur J Surg Oncol; 2009 Aug; 35(8):870-6. PubMed ID: 19179039
[TBL] [Abstract][Full Text] [Related]
26. Clinical significance of serum hepatocyte growth factor levels in liver diseases.
Hioki O; Watanabe A; Minemura M; Tsuchida T
J Med; 1993; 24(1):35-46. PubMed ID: 7684768
[TBL] [Abstract][Full Text] [Related]
27. [Significance of serum carnitine in patients with liver diseases].
Lin XH; Jiao LL; Xu GB; Tian GS
Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):367-9. PubMed ID: 16732913
[TBL] [Abstract][Full Text] [Related]
28. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
[TBL] [Abstract][Full Text] [Related]
29. Serum hyaluronic acid as a marker of hepatic fibrosis.
Khan JA; Khan FA; Dilawar M; Ijaz A; Khan NA; Mehmood T
J Coll Physicians Surg Pak; 2007 Jun; 17(6):323-6. PubMed ID: 17623578
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of relationship between CA-125 levels and ascites in patients with liver cirrhosis.
Kayadibi H; Sertoglu E; Uyanik M
J Coll Physicians Surg Pak; 2014 Nov; 24(11):873. PubMed ID: 25404453
[No Abstract] [Full Text] [Related]
31. Coexistence of struma ovarii with marked ascites and elevated CA-125 levels: case report and literature review.
Mui MP; Tam KF; Tam FK; Ngan HY
Arch Gynecol Obstet; 2009 May; 279(5):753-7. PubMed ID: 18807056
[TBL] [Abstract][Full Text] [Related]
32. Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C.
Fontanges T; Bailly F; Trepo E; Chevallier M; Maynard-Muet M; Nalet B; Beorchia S; Pillon D; Moindrot H; Froissart B; Slaoui M; Tinel X; Pradat P; Trepo C
Gastroenterol Clin Biol; 2008 Oct; 32(10):858-65. PubMed ID: 18775614
[TBL] [Abstract][Full Text] [Related]
33. [Clinical analysis of benign pelvic mass with high serum levels of CA(125)].
Zhang X; Wu LY; Li XJ; Li HJ; Zhang R; Liu LY
Zhonghua Fu Chan Ke Za Zhi; 2005 Mar; 40(3):178-82. PubMed ID: 15840313
[TBL] [Abstract][Full Text] [Related]
34. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
35. Clinical and laboratory evaluation of CA 19-9 in cirrhotic patients.
Collazos J
Eur J Med; 1992; 1(4):215-8. PubMed ID: 1341447
[TBL] [Abstract][Full Text] [Related]
36. [Increased CA-125 also in liver cirrhosis].
Siboni A; Kassem V; Vemmelund S; Petersen PL; Jelert H
Ugeskr Laeger; 2005 Jan; 167(2):189-90; author reply 190. PubMed ID: 15697137
[No Abstract] [Full Text] [Related]
37. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
[TBL] [Abstract][Full Text] [Related]
38. Ascites and highly elevated CA-125 levels in a case of peritoneal tuberculosis.
Younossian AB; Rochat T; Favre L; Janssens JP
Scand J Infect Dis; 2006; 38(3):216-8. PubMed ID: 16500786
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum CA-125 levels: hepatitis or ascites?
Sevinc A; Buyukberber S; Sari R
Gynecol Oncol; 2000 Jan; 76(1):141-2. PubMed ID: 10620461
[No Abstract] [Full Text] [Related]
40. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
